For decades, publishing a paper in Nature was regarded as the ultimate academic achievement in China – a fast track to promotions, research grants, hospital appointments and elite national talent programmes.
But a growing wave of academic fraud allegations could be turning that prestige into a liability.
Over the past two months, Chinese social media platforms have been flooded with accusations targeting papers published in Nature and its subsidiaries, including Nature Cancer, Nature Cell…
